PO
Predictive Oncology Inc.
POAI · NASDAQ
$5.95 N/A (+$5.95)
Piotroski F-Score Weak
3/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A Debt/Assets N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
46 /100
Moderate Beta 1.35x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o POAI
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Raymond F. Vennare
Employees
23
Headquarters
Pittsburgh